Advancing Patient Care Through Intelligent Medical Device Innovation
Pioneering Precision in Blood Technology
Established by leaders in the medical device industry, CuraNova was founded with a vision to redefine the standards of blood technology. Our team brings together decades of expertise in apheresis, plasma exchange, and therapeutic systems, all unified by a passion for innovation and patient-centered care.
At the core of CuraNova’s mission is the development of adaptive, automated systems that leverage artificial intelligence to deliver safe, precise, and efficient therapies. Our solutions are designed in close collaboration with clinicians, ensuring that every innovation addresses real-world challenges in hospitals and healthcare settings.
We are driven by a commitment to clinical excellence, continuous improvement, and ethical responsibility. CuraNova’s values of integrity, collaboration, and innovation inform every aspect of our work, from research and development to implementation and support.
Our leadership team comprises renowned experts in medical engineering, clinical practice, and digital health. Their guidance ensures CuraNova remains at the forefront of technological advancement, always striving to deliver measurable benefits to both healthcare providers and patients.
Advancing Patient Outcomes Through Intelligent Blood Technology
Our Distinctive Advantages
Innovative Solutions Shaping the Future of Blood Therapy
Smart technology for tailored therapies
AI-Driven Precision
Harnessing advanced artificial intelligence, our systems adapt in real time to patient-specific needs, optimizing blood component separation for superior clinical accuracy and safety.
Seamless integration for clinical efficiency
Hospital Workflow Innovation
CuraNova solutions integrate seamlessly into clinical environments, streamlining workflows and supporting medical teams in delivering efficient, high-quality care.
Delivering measurable patient benefits
Proven Clinical Outcomes
Our focus on therapeutic efficacy results in significant improvements in patient outcomes, ensuring every procedure is both safe and effective.
Meet the CuraNova Leadership
We are a dedicated team of professionals committed to delivering excellence.
Dr. Evelyn Chen
Chief Executive Officer
Thomas Berger
Chief Technology Officer
Dr. Priya Kapoor
Director of Clinical Innovation
Michael Andersson
Head of Product Engineering
Our Values and Ethical Commitments
At CuraNova, our work is guided by a steadfast commitment to the highest standards of patient safety, clinical precision, and ethical responsibility. Every therapeutic system we develop is designed to advance the quality and reliability of apheresis and blood component separation, ensuring each intervention supports optimal patient outcomes.
We prioritize transparency, rigorous quality control, and continuous improvement across all stages of innovation. Our value-driven approach fosters trust with healthcare providers and patients alike, reinforcing our dedication to delivering solutions that are both safe and effective.
Integrity, collaboration, and respect for all stakeholders shape our decision-making. By upholding these core values, CuraNova empowers clinicians and hospitals to achieve superior results, driving meaningful progress in medical device technology.
Connect With CuraNova
Discover how CuraNova’s leadership and innovative medical device solutions are advancing clinical efficiency and improving patient outcomes worldwide. Reach out to explore collaboration opportunities or to learn more about our impact in healthcare.